In this @AdvSciNews study, scientists show that dual-targeting small extracellular vesicles, derived from #MSCs, have the potential to boost 🔋 the immune inhibitory signaling in synergy and slow down #TransplantRejection. Full article: 🔗 https://t.co/…
Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection https://t.co/FjuFiu5mRd https://t.co/sbXcnXHi1a
Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection https://t.co/0LOvb1KZND https://t.co/l8beP6JxCp
New article: Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection https://t.co/kqmXBBkeg5 #kidneycancer #oncology https://t.co/3XfXpXpTWR